Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Vaccine ; 37(16): 2208-2215, 2019 04 10.
Article in English | MEDLINE | ID: mdl-30879829

ABSTRACT

BACKGROUND: Two electrochemiluminescence (ECL) assays were developed which, together, can simultaneously measure serum antibodies against pneumococcal capsular polysaccharides (PnPS) for 17 serotypes. The assays were validated for the 13 PnPS included in the 13-valent pneumococcal conjugate vaccine (PCV13). As recommended by the World Health Organization (WHO), we compared the ECL assays with the WHO reference enzyme-linked immunosorbent assay (ELISA) and derived a threshold corresponding to the 0.35 µg/mL threshold established for the WHO reference ELISA for the non-inferiority comparison and licensure of new PCVs against invasive pneumococcal disease. METHODS: A panel of 452 serum samples from children vaccinated with one of the three licensed PCVs was assessed with the ECL assays and the WHO reference ELISA. The ECL assay threshold for the aggregated seven PnPS included in the 7-valent PCV (PCV7) and serotype-specific thresholds were determined using a receiver operating characteristics (ROC) curve-based approach and Deming regression. To evaluate concordance between the ECL assays and the WHO reference ELISA, serostatus agreement rates between both assays and geometric means of the ratios (GMRs) of concentrations obtained with both assays were calculated. RESULTS: The thresholds for the seven aggregated PCV7 serotypes obtained with the ROC curve-based approach and Deming regression approximated 0.35 µg/mL (0.38 and 0.34 µg/mL, respectively). Individual thresholds for the PCV13 serotypes ranged between 0.24 and 0.51 µg/mL across both approaches. Serostatus agreement rates using a 0.35 µg/mL threshold for both assays were ≥86.9% for all PCV13 serotypes. GMRs ranged between 0.85 and 1.25 for 11/13 serotypes and were <1.29 for the two remaining serotypes. CONCLUSION: The ECL assays were comparable to the WHO reference ELISA and offer a sensitive, time- and serum volume-saving method to quantify serotype-specific anti-PnPS antibodies in pediatric sera. A 0.35 µg/mL threshold will be used for each PCV13 serotype to assess PCV immunogenicity in clinical trials.


Subject(s)
Antibodies, Bacterial/immunology , Pneumococcal Infections/epidemiology , Pneumococcal Infections/immunology , Polysaccharides, Bacterial/immunology , Streptococcus pneumoniae/immunology , Antibodies, Bacterial/blood , Enzyme-Linked Immunosorbent Assay/methods , Enzyme-Linked Immunosorbent Assay/standards , Heptavalent Pneumococcal Conjugate Vaccine/immunology , Humans , Luminescent Measurements/methods , Luminescent Measurements/standards , Pneumococcal Infections/prevention & control , Pneumococcal Vaccines/immunology , ROC Curve , Reproducibility of Results , Serogroup , Streptococcus pneumoniae/classification
2.
Immunity ; 38(4): 742-53, 2013 Apr 18.
Article in English | MEDLINE | ID: mdl-23601686

ABSTRACT

MicroRNAs (miRNAs) regulate the function of several immune cells, but their role in promoting CD8(+) T cell immunity remains unknown. Here we report that miRNA-155 is required for CD8(+) T cell responses to both virus and cancer. In the absence of miRNA-155, accumulation of effector CD8(+) T cells was severely reduced during acute and chronic viral infections and control of virus replication was impaired. Similarly, Mir155(-/-) CD8(+) T cells were ineffective at controlling tumor growth, whereas miRNA-155 overexpression enhanced the antitumor response. miRNA-155 deficiency resulted in accumulation of suppressor of cytokine signaling-1 (SOCS-1) causing defective cytokine signaling through STAT5. Consistently, enforced expression of SOCS-1 in CD8(+) T cells phenocopied the miRNA-155 deficiency, whereas SOCS-1 silencing augmented tumor destruction. These findings identify miRNA-155 and its target SOCS-1 as key regulators of effector CD8(+) T cells that can be modulated to potentiate immunotherapies for infectious diseases and cancer.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Lymphocytic Choriomeningitis/immunology , Lymphocytic choriomeningitis virus/physiology , Melanoma, Experimental/immunology , MicroRNAs/metabolism , Adoptive Transfer , Animals , Apoptosis/genetics , Cell Proliferation , Cells, Cultured , Cytokines/metabolism , Cytotoxicity, Immunologic/genetics , Humans , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , MicroRNAs/genetics , RNA, Small Interfering/genetics , STAT6 Transcription Factor/metabolism , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling Proteins/metabolism , Virus Replication/genetics
3.
PLoS Pathog ; 8(3): e1002560, 2012.
Article in English | MEDLINE | ID: mdl-22396647

ABSTRACT

The protective immune response to intracellular parasites involves in most cases the differentiation of IFNγ-secreting CD4(+) T helper (Th) 1 cells. Notch receptors regulate cell differentiation during development but their implication in the polarization of peripheral CD4(+) T helper 1 cells is not well understood. Of the four Notch receptors, only Notch1 (N1) and Notch2 (N2) are expressed on activated CD4(+) T cells. To investigate the role of Notch in Th1 cell differentiation following parasite infection, mice with T cell-specific gene ablation of N1, N2 or both (N1N2(ΔCD4Cre)) were infected with the protozoan parasite Leishmania major. N1N2(ΔCD4Cre) mice, on the C57BL/6 L. major-resistant genetic background, developed unhealing lesions and uncontrolled parasitemia. Susceptibility correlated with impaired secretion of IFNγ by draining lymph node CD4(+) T cells and increased secretion of the IL-5 and IL-13 Th2 cytokines. Mice with single inactivation of N1 or N2 in their T cells were resistant to infection and developed a protective Th1 immune response, showing that CD4(+) T cell expression of N1 or N2 is redundant in driving Th1 differentiation. Furthermore, we show that Notch signaling is required for the secretion of IFNγ by Th1 cells. This effect is independent of CSL/RBP-Jκ, the major effector of Notch receptors, since L. major-infected mice with a RBP-Jκ deletion in their T cells were able to develop IFNγ-secreting Th1 cells, kill parasites and heal their lesions. Collectively, we demonstrate here a crucial role for RBP-Jκ-independent Notch signaling in the differentiation of a functional Th1 immune response following L. major infection.


Subject(s)
Interferon-gamma/metabolism , Leishmania major/physiology , Leishmaniasis, Cutaneous/immunology , Receptor, Notch1/metabolism , Receptor, Notch2/metabolism , Th1 Cells/metabolism , Animals , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Gene Expression , Host-Parasite Interactions , Leishmaniasis, Cutaneous/genetics , Leishmaniasis, Cutaneous/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Receptor, Notch1/genetics , Receptor, Notch2/genetics , Signal Transduction
4.
J Immunol ; 187(1): 110-7, 2011 Jul 01.
Article in English | MEDLINE | ID: mdl-21632721

ABSTRACT

Activating and inhibitory NK receptors regulate the development and effector functions of NK cells via their ITAM and ITIM motifs, which recruit protein tyrosine kinases and phosphatases, respectively. In the T cell lineage, inhibitory Ly49 receptors are expressed by a subset of activated T cells and by CD1d-restricted NKT cells, but virtually no expression of activating Ly49 receptors is observed. Using mice transgenic for the activating receptor Ly49D and its associated ITAM signaling DAP12 chain, we show in this article that Ly49D-mediated ITAM signaling in immature thymocytes impairs development due to a block in maturation from the double negative (DN) to double positive (DP) stages. A large proportion of Ly49D/DAP12 transgenic thymocytes were able to bypass the pre-TCR checkpoint at the DN3 stage, leading to the appearance of unusual populations of DN4 and DP cells that lacked expression of intracellular (ic) TCRß-chain. High levels of CD5 were expressed on ic TCRß(-) DN and DP thymocytes from Ly49D/DAP12 transgenic mice, further suggesting that Ly49D-mediated ITAM signaling mimics physiological ITAM signaling via the pre-TCR. We also observed unusual ic TCRß(-) single positive thymocytes with an immature CD24(high) phenotype that were not found in the periphery. Importantly, thymocyte development was completely rescued by expression of an Ly49A transgene in Ly49D/DAP12 transgenic mice, indicating that Ly49A-mediated ITIM signaling can fully counteract ITAM signaling via Ly49D/DAP12. Collectively, our data indicate that inappropriate ITAM signaling by activating NK receptors on immature thymocytes can subvert T cell development by bypassing the pre-TCR checkpoint.


Subject(s)
Cell Differentiation/immunology , Lymphocyte Activation/immunology , NK Cell Lectin-Like Receptor Subfamily A/physiology , Receptors, Antigen, T-Cell/genetics , Signal Transduction/immunology , T-Lymphocyte Subsets/immunology , Tyrosine/genetics , Adaptor Proteins, Signal Transducing/antagonists & inhibitors , Adaptor Proteins, Signal Transducing/genetics , Animals , Cell Cycle/genetics , Cell Cycle/immunology , Cell Differentiation/genetics , H-2 Antigens/genetics , Histocompatibility Antigen H-2D , Humans , Lymphocyte Activation/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , NK Cell Lectin-Like Receptor Subfamily A/antagonists & inhibitors , NK Cell Lectin-Like Receptor Subfamily A/genetics , Receptors, Antigen, T-Cell/antagonists & inhibitors , Receptors, Antigen, T-Cell/biosynthesis , Signal Transduction/genetics , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/pathology
5.
J Immunol ; 183(11): 7212-22, 2009 Dec 01.
Article in English | MEDLINE | ID: mdl-19915064

ABSTRACT

It is well established that Notch signaling plays a critical role at multiple stages of T cell development and activation. However, detailed analysis of the cellular and molecular events associated with Notch signaling in T cells is hampered by the lack of reagents that can unambiguously measure cell surface Notch receptor expression. Using novel rat mAbs directed against the extracellular domains of Notch1 and Notch2, we find that Notch1 is already highly expressed on common lymphoid precursors in the bone marrow and remains at high levels during intrathymic maturation of CD4(-)CD8(-) thymocytes. Notch1 is progressively down-regulated at the CD4(+)CD8(+) and mature CD4(+) or CD8(+) thymic stages and is expressed at low levels on peripheral T cells. Immunofluorescence staining of thymus cryosections further revealed a localization of Notch1(+)CD25(-) cells adjacent to the thymus capsule. Notch1 was up-regulated on peripheral T cells following activation in vitro with anti-CD3 mAbs or infection in vivo with lymphocytic chorio-meningitis virus or Leishmania major. In contrast to Notch1, Notch2 was expressed at intermediate levels on common lymphoid precursors and CD117(+) early intrathymic subsets, but disappeared completely at subsequent stages of T cell development. However, transient up-regulation of Notch2 was also observed on peripheral T cells following anti-CD3 stimulation. Collectively our novel mAbs reveal a dynamic regulation of Notch1 and Notch2 surface expression during T cell development and activation. Furthermore they provide an important resource for future analysis of Notch receptors in various tissues including the hematopoietic system.


Subject(s)
Antibodies, Monoclonal/immunology , Lymphocyte Activation/immunology , Receptor, Notch1/biosynthesis , Receptor, Notch2/biosynthesis , Animals , Antibody Specificity , Cell Differentiation , Cell Membrane/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Fluorescent Antibody Technique , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Rats , Receptor, Notch1/immunology , Receptor, Notch2/immunology , Signal Transduction/immunology , Stem Cells/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/metabolism
6.
J Immunol ; 182(1): 183-92, 2009 Jan 01.
Article in English | MEDLINE | ID: mdl-19109149

ABSTRACT

Recent data showing expression of activating NK receptors (NKR) by conventional T lymphocytes raise the question of their role in the triggering of TCR-independent responses that could be damaging for the host. Transgenic mice expressing the activating receptor Ly49D/DAP12 offer the opportunity to better understand the relevance of ITAM signaling in the biology of T cells. In vitro experiments showed that Ly49D engagement on T lymphocytes by a cognate MHC class I ligand expressed by Chinese hamster ovary (CHO) cells or by specific Ab triggered cellular activation of both CD4 and CD8 populations with modulation of activation markers and cytokine production. The forced expression of the ITAM signaling chain DAP12 is mandatory for Ly49D-transgenic T cell activation. In addition, Ly49D stimulation induced T lymphocyte proliferation, which was much stronger for CD8 T cells. Phenotypic analysis of anti-Ly49D-stimulated CD8 T cells and their ability to produce high levels of IFN-gamma and to kill target cells indicate that Ly49D ligation generates effector cytotoxic CD8 T cells. Ly49D engagement by itself also triggered cytotoxic activity of activated CD8 T cells. Adoptive transfer experiments confirmed that Ly49D-transgenic CD8 T cells are able to control growth of CHO tumor cells or RMA cells transfected with Hm1-C4, the Ly49D ligand normally expressed by CHO. In conclusion, Ly49D engagement on T cells leads to T cell activation and to a full range of TCR-independent effector functions of CD8 T cells.


Subject(s)
Lymphocyte Activation/immunology , Mastocytoma/immunology , NK Cell Lectin-Like Receptor Subfamily A/metabolism , Receptors, Antigen, T-Cell/physiology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , Thymoma/immunology , Animals , CHO Cells , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Line, Tumor , Cricetinae , Cricetulus , Cytotoxicity Tests, Immunologic , Ligands , Lymphocyte Activation/genetics , Mastocytoma/pathology , Mastocytoma/prevention & control , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Transgenic , NK Cell Lectin-Like Receptor Subfamily A/genetics , NK Cell Lectin-Like Receptor Subfamily A/physiology , T-Lymphocytes, Cytotoxic/cytology , T-Lymphocytes, Cytotoxic/metabolism , Thymoma/pathology , Thymoma/prevention & control
7.
J Immunol ; 181(12): 8199-203, 2008 Dec 15.
Article in English | MEDLINE | ID: mdl-19050235

ABSTRACT

Interactions between Notch1 receptors on lymphoid progenitors and Delta-like 4 (DL4) ligands on cortical thymic epithelial cells (cTEC) are essential for T cell lineage commitment, expansion, and maturation in the thymus. Using a novel mAb against DL4, we show that DL4 levels on cTEC are very high in the fetal and neonatal thymus when thymocyte expansion is maximal but decrease dramatically in the adult when steady-state homeostasis is attained. Analysis of mutant mouse strains where thymocyte development is blocked at different stages indicates that lymphostromal interactions ("thymus crosstalk") are required for DL4 down-regulation on cTEC. Reconstitution of thymocyte development in these mutant mice further suggests that maturation of thymocytes to the CD4(+)CD8(+) stage and concomitant expansion are needed to promote DL4 down-regulation on cTEC. Collectively, our data support a model where thymic crosstalk quantitatively regulates the rate of Notch1-dependent thymopoiesis by controlling DL4 expression levels on cTEC.


Subject(s)
Cell Communication/immunology , Epithelial Cells/immunology , Epithelial Cells/metabolism , Membrane Proteins/biosynthesis , Thymus Gland/cytology , Thymus Gland/immunology , Adaptor Proteins, Signal Transducing , Animals , Animals, Newborn , Calcium-Binding Proteins , Cell Communication/genetics , Down-Regulation/immunology , Intracellular Signaling Peptides and Proteins/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins/genetics , Lymphopoiesis/genetics , Lymphopoiesis/immunology , Male , Membrane Proteins/antagonists & inhibitors , Membrane Proteins/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Models, Immunological , Rats , Receptor, Notch1/physiology , Stromal Cells/cytology , Stromal Cells/immunology , Stromal Cells/metabolism , Thymus Gland/embryology , Thymus Gland/metabolism
8.
J Immunol ; 176(5): 3149-56, 2006 Mar 01.
Article in English | MEDLINE | ID: mdl-16493074

ABSTRACT

We have previously described the human osteoclast associated receptor (hOSCAR), expressed in all cells of the myeloid lineage, and its immune functions. This receptor, which associates with the FcRgamma chain to transduce an activating signal, induces calcium flux in monocytes and dendritic cells, and modulates specific responses of dendritic cells. In this study, we have examined the effects of hOSCAR ligation on various proinflammatory responses of monocytes and neutrophils. Monocytes stimulated via hOSCAR ligation released IL-8/CXCL8 and other chemokines such as epithelial neutrophil-activating peptide-78/CXCL5, macrophage-derived chemokine/CCL22, and MCP-1/CCL2 and up-regulated markers involved in cell adhesion and costimulatory functions. Monocytes stimulated via hOSCAR in the absence of survival factors had an increased life span. Although the life span of neutrophils was unaffected, these cells, when stimulated via hOSCAR, rapidly released reactive oxygen intermediates, degranulated lactoferrin, myeloperoxidase, and matrix metalloproteinase-9 and also secreted IL-8/CXCL8. Neutrophils also underwent changes in cell surface molecule expression with the cleavage of CD62L and increased expression of CD11b and CD66b after 2-h stimulations. Finally, we demonstrated synergy between hOSCAR and TLR ligands on both monocytes and neutrophils, with up to 8-fold increases in cytokine secretion when hOSCAR was cross-linked in the presence of LPS or R-848. Overall, our data demonstrate that hOSCAR is a functional receptor on monocytes and neutrophils, involved in the induction of the primary proinflammatory cascade and the initiation of downstream immune responses.


Subject(s)
Adjuvants, Immunologic/metabolism , Inflammation Mediators/metabolism , Monocytes/pathology , Neutrophils/pathology , Receptors, Cell Surface/metabolism , Receptors, IgG/metabolism , Adjuvants, Immunologic/physiology , Cell Degranulation/immunology , Cell Degranulation/physiology , Cell Survival/immunology , Cell Survival/physiology , Cells, Cultured , Humans , Immunity, Innate , Immunophenotyping , Inflammation Mediators/physiology , Ligands , Monocytes/metabolism , Neutrophils/metabolism , Receptors, Cell Surface/physiology , Signal Transduction/immunology , Toll-Like Receptors/metabolism
9.
J Biol Chem ; 280(46): 38133-45, 2005 Nov 18.
Article in English | MEDLINE | ID: mdl-16144834

ABSTRACT

Studies involving Toll-like receptor 3 (TLR3)-deficient mice suggest that this receptor binds double-stranded RNA. In the present study, we analyzed ligand/receptor interactions and receptor-proximal events leading to TLR3 activation. The mutagenesis approach showed that certain cysteine residues and glycosylation in TLR3 amino-terminal leucine-rich repeats were necessary for ligand-induced signaling. Furthermore, inactive mutants had a dominant negative effect, suggesting that the signaling module is a multimer. We constructed a chimeric molecule fusing the amino-terminal ectodomain of TLR3 to the transmembrane and carboxyl terminal domains of CD32a containing an immunoreceptor tyrosine-based motif. Expression of TLR3-CD32 in HEK293T cells and the myeloid cell line U937 resulted in surface localization of the receptor, whereas the nonrecombinant molecule was intracellularly localized. The synthetic double-stranded RNAs poly(I-C) and poly(A-U) induced calcium mobilization in a TLR3-CD32 stably transfected U937 clone but not in control cells transfected with other constructs. An anti-TLR3 antibody also induced Ca(2+) flux but only when cross-linked by a secondary anti-immunoglobulin antibody, confirming that multimerization by the ligand is a requirement for signaling. The inhibitors of lysosome maturation, bafilomycin and chloroquine, inhibited the poly(I-C)-induced biological response in immune cells, showing that TLR3 interacted with its ligand in acidic subcellular compartments. Furthermore, TLR3-CD32 activation with poly(I-C) was only observed within a narrow pH window (pH 5.7-6.7), whereas anti-TLR3-mediated Ca(2+) flux was pH-insensitive. The importance of an acidic pH for TLR3-ligand interaction becomes critical when using oligomeric poly(I-C) (15-40-mers). These observations demonstrate that engagement of TLR3 by poly(I-C) at an acidic pH, probably in early phagolysosomes or endosomes, induces receptor aggregation leading to signaling.


Subject(s)
DNA/metabolism , Toll-Like Receptor 3/metabolism , Amino Acid Sequence , Antigens, CD/chemistry , Antirheumatic Agents/pharmacology , Base Sequence , Binding Sites , Blotting, Western , Calcium/metabolism , Cell Line , Cell Membrane/metabolism , Cell Separation , Chloroquine/chemistry , Cross-Linking Reagents/pharmacology , Cysteine/chemistry , Cysteine/metabolism , Cytokines/metabolism , Dendritic Cells/metabolism , Dimerization , Dose-Response Relationship, Drug , Endosomes/metabolism , Enzyme Inhibitors/pharmacology , Flow Cytometry , Genes, Dominant , Genes, Reporter , Glycosylation , Humans , Hydrogen-Ion Concentration , Leucine/chemistry , Leukocytes, Mononuclear/metabolism , Ligands , Luciferases/metabolism , Lysosomes/chemistry , Lysosomes/metabolism , Macrolides/pharmacology , Molecular Sequence Data , Mutagenesis, Site-Directed , Mutation , NF-kappa B/metabolism , Phagosomes/chemistry , Protein Binding , Protein Structure, Tertiary , Receptors, IgG/biosynthesis , Receptors, IgG/chemistry , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid , Signal Transduction , Time Factors , Toll-Like Receptor 3/chemistry , Transfection , Tyrosine/chemistry
10.
J Immunol ; 174(11): 6757-63, 2005 Jun 01.
Article in English | MEDLINE | ID: mdl-15905516

ABSTRACT

Immature dendritic cells (DCs) derived from freshly isolated human monocytes were used to evaluate the effect of the inhibiting receptor CD85j (leukocyte Ig-like receptor-1/ILT2) on activation induced by cross-linking of the human osteoclast-associated receptor (hOSCAR). CD85j and hOSCAR were expressed consistently at the same density on monocytes and on monocyte-derived DCs (both immature and mature). Cross-linking of hOSCAR, which activates via the FcR-associated gamma-chain, induced Ca(2+) flux in DCs. Concomitant cross-linking of anti-CD85j mAb abolished this early activation event. Likewise, CD85j stimulation strongly reduced IL-8 and IL-12 production by hOSCAR-activated DCs. Inhibition of DCs via CD85j also impaired their ability to enhance Ag-specific T cell proliferation induced by hOSCAR. Finally, because hOSCAR prevents apoptosis of DCs in the absence of growth/survival factors, CD85j cross-linking was able to counteract completely this antiapoptotic effect and to reduce Bcl-2 expression enhanced by hOSCAR stimulation. Thus, CD85j is an inhibiting receptor that is functional in human DCs.


Subject(s)
Antigens, CD/physiology , Dendritic Cells/immunology , Growth Inhibitors/physiology , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/physiology , Receptors, Immunologic/physiology , Antigens, CD/biosynthesis , Apoptosis/immunology , Calcium/antagonists & inhibitors , Calcium/metabolism , Calcium Signaling/immunology , Cell Differentiation/immunology , Cell Separation , Cells, Cultured , Cytokines/antagonists & inhibitors , Cytokines/biosynthesis , Dendritic Cells/cytology , Dendritic Cells/metabolism , Down-Regulation/immunology , Epitopes, T-Lymphocyte/immunology , Humans , Leukocyte Immunoglobulin-like Receptor B1 , Lymphocyte Activation/immunology , Monocytes/cytology , Monocytes/immunology , Monocytes/metabolism , Osteoclasts/immunology , Osteoclasts/metabolism , Receptors, Cell Surface/biosynthesis , Receptors, Immunologic/biosynthesis , T-Lymphocyte Subsets/immunology
11.
J Immunol ; 174(5): 2942-50, 2005 Mar 01.
Article in English | MEDLINE | ID: mdl-15728506

ABSTRACT

Human TLR10 is an orphan member of the TLR family. Genomic studies indicate that TLR10 is in a locus that also contains TLR1 and TLR6, two receptors known to function as coreceptors for TLR2. We have shown that TLR10 was not only able to homodimerize but also heterodimerized with TLRs 1 and 2. In addition, unlike TLR1 and TLR6, TLR10 was expressed in a highly restricted fashion as a highly N-glycosylated protein, which we detected in B cell lines, B cells from peripheral blood, and plasmacytoid dendritic cells from tonsil. We were also able to detect TLR10 in a CD1a(+) DC subset derived from CD34(+) progenitor cells which resemble Langerhans cells in the epidermis. Although we were unable to identify a specific ligand for TLR10, by using a recombinant CD4TLR10 molecule we also demonstrated that TLR10 directly associates with MyD88, the common Toll IL-1 receptor domain adapter. Additionally, we have characterized regions in the Toll IL-1 receptor domain of TLR10 that are essential in the activation of promoters from certain inflammatory cytokines. Even though TLR10 expression has not been detected in mice, we have identified a partial genomic sequence of the TLR10 gene that was present but nonfunctional and disrupted by a retroviral insertion in all mouse strains tested. However, a complete TLR10 sequence could be detected in the rat genome, indicating that a functional copy may be preserved in this species.


Subject(s)
Antigens, Differentiation/physiology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Dendritic Cells/immunology , Dendritic Cells/metabolism , Gene Expression Regulation/immunology , Receptors, Cell Surface/physiology , Receptors, Immunologic/physiology , Adaptor Proteins, Signal Transducing , Adult , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , CD4 Antigens/genetics , CD4 Antigens/metabolism , Cell Line , Glycosylation , Humans , Membrane Glycoproteins/genetics , Mice , Molecular Sequence Data , Myeloid Differentiation Factor 88 , Promoter Regions, Genetic , Protein Structure, Tertiary/genetics , Rats , Receptors, Cell Surface/biosynthesis , Receptors, Interleukin-1/genetics , Sequence Homology, Amino Acid , Signal Transduction/genetics , Signal Transduction/immunology , Toll-Like Receptor 10
12.
Blood ; 105(9): 3623-32, 2005 May 01.
Article in English | MEDLINE | ID: mdl-15650060

ABSTRACT

We previously reported the characterization of human osteoclast-associated receptor (hOSCAR), a novel Fc receptor gamma-chain (FcRgamma)-associated receptor expressed by myeloid cells. Here we show that ligation of hOSCAR by specific antibodies promotes dendritic cell (DC) survival by an extracellular signal-regulated kinase (ERK)- and phosphatidylinositol 3-kinase (PI3K)-dependent pathway, linked to expression of the Bcl-2 and Bcl-x(L) antiapoptotic molecules. Crosslinking of hOSCAR leads to maturation of DCs, as demonstrated by up-regulation of maturation markers, decrease in dextran uptake capacity, and secretion of immunesystem effectors such as interleukin-8 (IL-8)/CXC chemokine ligand 8 (CXCL8), IL-12 p40, monocyte chemoattractant protein-1 (MCP-1)/chemokine receptor ligand 2 (CCL2) and macrophage-derived chemokine (MDC)/CCL22. Stimulation of hOSCAR acts in conjunction with the Toll-like receptor (TLR) ligands, lipopolysaccharide (LPS), R-848, and polyinosinic-polycytidylic acid (poly(I:C)), to increase the expression of maturation markers, and to modulate cytokine release. A PI3K-dependent up-regulation of IL-10 release is observed with all the TLR ligands used, whereas regulation of IL-12 production is variable depending on the TLR stimulated. hOSCAR engagement on DCs did not significantly increase the proliferation of naive T cells; however, when co-incubated with TLR ligands, an enhanced proliferation was observed. The percentage of interferon (IFN)-gamma-producing T cells is decreased when hOSCAR engagement is combined with LPS stimulation. Altogether, these data suggest that hOSCAR may modulate the responses of both innate resistance and adaptive immunity.


Subject(s)
Dendritic Cells/immunology , Membrane Glycoproteins/pharmacology , Receptors, Cell Surface/metabolism , Receptors, IgG/immunology , Antibodies, Monoclonal , Cell Differentiation , Cell Proliferation/drug effects , Cell Survival , Cells, Cultured , Cytokines/biosynthesis , Dendritic Cells/cytology , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Phosphatidylinositol 3-Kinases/metabolism , Protein Binding , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Receptors, IgG/metabolism , T-Lymphocytes/cytology , T-Lymphocytes/immunology , Toll-Like Receptors , bcl-X Protein
13.
Blood ; 104(5): 1386-95, 2004 Sep 01.
Article in English | MEDLINE | ID: mdl-15155468

ABSTRACT

We have isolated a novel cell surface molecule, the human homolog of osteoclast-associated receptor (OSCAR). Unlike mouse OSCAR, hOSCAR is widely transcribed in cells of the myeloid lineage. Notably, hOSCAR is expressed on circulating blood monocytes and CD11c(+) dendritic cells but not on T and B cells. hOSCAR is continually expressed during differentiation of CD14(+) monocytes into dendritic cells and maintained after maturation. hOSCAR associates with the FcRgamma as shown by translocation of FcRgamma to the cell surface in presence of hOSCAR and coimmunoprecipitation from transfected cell lines and ex vivo cells. Engagement of hOSCAR with specific mAb leads to Ca(2+) mobilization and cytokine release, indicators of cellular activation. Endocytosis of the receptor in dendritic cells was observed, followed by passage of the internalized material into Lamp-1(+) and HLA-DR(+) compartments, suggesting a role in antigen uptake and presentation. Dendritic cells were able to stimulate a T-cell clone specific for an epitope of mouse IgG1 after uptake and processing of the hOSCAR-specific antibody, demonstrating the capacity of this receptor to mediate antigen presentation. hOSCAR thus represents a novel class of molecule expressed by dendritic cells involved in the initiation of the immune response.


Subject(s)
Antigen Presentation/physiology , Dendritic Cells/physiology , Monocytes/physiology , Receptors, Cell Surface/genetics , Receptors, Cell Surface/metabolism , Receptors, IgG/metabolism , Antigens/metabolism , Antigens, Surface/genetics , Antigens, Surface/immunology , Antigens, Surface/metabolism , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Calcium/metabolism , Cytokines/metabolism , Endocytosis/immunology , Glycosylation , Humans , RNA, Messenger/analysis , Receptors, Cell Surface/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...